All News
Coagulopathy and Antiphospholipid Antibodies with Covid-19
The New England Journal of Medicine has featured a report of three COVID infected patients, who developed peripheral and central infarcts with a antiphospholipid antibodies.
Read ArticleTNR - Grand Rounds: Safety of Biologics & New Agents
On Tuesday, April 7th, RheumNow hosted its first Tuesday Nite Rheumatology webinar - kicking off a two-month series of Rheumatology Grand Rounds lectures. The first session featured Jack Cush, MD (UT Southwestern) who lectured on "The Safety of Biologics and Newer Agents".
Read ArticleIncubation Period for COVID-19
The incubation period for coronavirus disease 2019 (COVID-19) has important implications for surveillance and control activities. The Annals of Internal Medicine reports a pooled analysis of confirmed COVID-19 cases January 4, 2020 and February 24, 2020.
Read ArticleTanezumab: A Win as Last-Ditch Osteoarthritis Tx
A phase III study of the nerve growth factor and monoclonal antibody tanezumab showed positive results in a refractory patient population with knee or hip osteoarthritis (OA) -- good enough that this agent may finally be approved after a long and rocky development road.
Read ArticleCOVID-19 Susceptibility: Why Do Some Become So Ill?
The differential susceptibility to COVID-19 infection is attributable to socioeconomic factors and genetic differences, that together with environmental factors, human-virus interactions, gender, perhaps blood type, and age-related senescence determine the immune response and the likelihood of developing disease.
Read ArticleNICE Guidelines on Managing Rheumatologic Conditions During COVID-19 Pandemic
On April 3rd, the National Institute for Health and Care Excellence (NICE) in the UK, published a rapid guideline for managing children and adults with rheumatological autoimmune, inflammatory and metabolic bone disorders during the COVID-19 pandemic, while protecting staff from infection.
Read Article
Links:
Dr. John Cush RheumNow ( View Tweet)

Dr. John Cush RheumNow ( View Tweet)



Dr. John Cush RheumNow ( View Tweet)

Dr. John Cush RheumNow ( View Tweet)

Dr. John Cush RheumNow ( View Tweet)

Dr. John Cush RheumNow ( View Tweet)


Links:
paul-peter tak paulpetertak ( View Tweet)

Leonard Calabrese LCalabreseDO ( View Tweet)

Maximilian Konig MaxKonigMD ( View Tweet)


Dr. John Cush RheumNow ( View Tweet)